These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 30824288)

  • 21. Challenges and advances of CRISPR-Cas9 genome editing in therapeutics.
    Stellos K; Musunuru K
    Cardiovasc Res; 2019 Feb; 115(2):e12-e14. PubMed ID: 30668679
    [No Abstract]   [Full Text] [Related]  

  • 22. Genome editing: The efficient tool CRISPR-Cpf1.
    Mahfouz MM
    Nat Plants; 2017 Mar; 3():17028. PubMed ID: 28260792
    [No Abstract]   [Full Text] [Related]  

  • 23. Gene targeting technologies in rats: zinc finger nucleases, transcription activator-like effector nucleases, and clustered regularly interspaced short palindromic repeats.
    Mashimo T
    Dev Growth Differ; 2014 Jan; 56(1):46-52. PubMed ID: 24372523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic engineering: Chemical control for CRISPR editing.
    Hilton IB; Gersbach CA
    Nat Chem Biol; 2017 Jan; 13(1):2-3. PubMed ID: 27820804
    [No Abstract]   [Full Text] [Related]  

  • 25. NIH supports call for moratorium on clinical uses of germline gene editing.
    Wolinetz CD; Collins FS
    Nature; 2019 Mar; 567(7747):175. PubMed ID: 30867615
    [No Abstract]   [Full Text] [Related]  

  • 26. In Vivo Delivery of CRISPR/Cas9 for Therapeutic Gene Editing: Progress and Challenges.
    Mout R; Ray M; Lee YW; Scaletti F; Rotello VM
    Bioconjug Chem; 2017 Apr; 28(4):880-884. PubMed ID: 28263568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clipping cancer with CRISPR: The precise gene-editing tool is showing promise in early cancer studies, although obstacles remain.
    Nelson B
    Cancer Cytopathol; 2018 Jan; 126(1):7-8. PubMed ID: 29328557
    [No Abstract]   [Full Text] [Related]  

  • 28. Designing Ethical Trials of Germline Gene Editing.
    Cwik B
    N Engl J Med; 2017 Nov; 377(20):1911-1913. PubMed ID: 29141166
    [No Abstract]   [Full Text] [Related]  

  • 29. Genome editing: proceed with caution.
    The Lancet
    Lancet; 2018 Jul; 392(10144):253. PubMed ID: 30064637
    [No Abstract]   [Full Text] [Related]  

  • 30. Inhibiting CRISPR.
    Rusk N
    Nat Methods; 2019 Mar; 16(3):218. PubMed ID: 30814697
    [No Abstract]   [Full Text] [Related]  

  • 31. Human Genome Editing and Ethical Considerations.
    Krishan K; Kanchan T; Singh B
    Sci Eng Ethics; 2016 Apr; 22(2):597-9. PubMed ID: 26154417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiplex Gene Editing in Rice Using the CRISPR-Cpf1 System.
    Wang M; Mao Y; Lu Y; Tao X; Zhu JK
    Mol Plant; 2017 Jul; 10(7):1011-1013. PubMed ID: 28315752
    [No Abstract]   [Full Text] [Related]  

  • 33. CRISPR hacks enable pinpoint repairs to genome.
    Dolgin E
    Nature; 2017 Oct; 550(7677):439-440. PubMed ID: 29072279
    [No Abstract]   [Full Text] [Related]  

  • 34. Genome Editing in Retinal Diseases using CRISPR Technology.
    Yiu G
    Ophthalmol Retina; 2018 Jan; 2(1):1-3. PubMed ID: 31047294
    [No Abstract]   [Full Text] [Related]  

  • 35. Gene therapy: In vivo gene editing in non-dividing cells.
    Waldron D
    Nat Rev Genet; 2017 Jan; 18(1):1. PubMed ID: 27916984
    [No Abstract]   [Full Text] [Related]  

  • 36. CRISPR-GE: A Convenient Software Toolkit for CRISPR-Based Genome Editing.
    Xie X; Ma X; Zhu Q; Zeng D; Li G; Liu YG
    Mol Plant; 2017 Sep; 10(9):1246-1249. PubMed ID: 28624544
    [No Abstract]   [Full Text] [Related]  

  • 37. A path to efficient gene editing.
    Urnov FD
    Nat Med; 2018 Jul; 24(7):899-900. PubMed ID: 29988144
    [No Abstract]   [Full Text] [Related]  

  • 38. Questioning the proposed translational pathway for germline genome editing.
    Baylis F
    Nat Hum Behav; 2019 Mar; 3(3):200. PubMed ID: 30953019
    [No Abstract]   [Full Text] [Related]  

  • 39. From CRISPR scissors to virus sensors.
    Kocak DD; Gersbach CA
    Nature; 2018 May; 557(7704):168-169. PubMed ID: 29730672
    [No Abstract]   [Full Text] [Related]  

  • 40. CRISPR patent ruling leaves license holders scrambling.
    Cohen J
    Science; 2017 Feb; 355(6327):786. PubMed ID: 28232532
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.